Exagen Investor Relations Material
Latest events
Q2 2025
Exagen
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Exagen Inc
Access all reports
Exagen Inc. is a life sciences company focused on transforming the diagnosis, prognosis, and management of autoimmune diseases. The company develops and commercializes advanced diagnostic solutions designed to provide actionable insights for physicians treating conditions such as lupus and rheumatoid arthritis. Exagen’s product portfolio includes proprietary tests and services that integrate genomic and proteomic technologies to support personalized patient care. The company is headquartered in Vista, California, and its shares are listed on the NASDAQ.
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
XGN
Country
🇺🇸 United States